Orthofix Medical/$OFIX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Ticker

$OFIX
Primary listing

Industry

Health Care Equipment & Supplies

Employees

1,616

ISIN

US68752M1080

Orthofix Medical Metrics

BasicAdvanced
$433M
-
-$3.72
0.88
-

What the Analysts think about Orthofix Medical

Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.

Bulls say / Bears say

Orthofix Medical's U.S. Spine Fixation and Orthopedics segments demonstrated robust growth, with net sales increases of 16% and 23% respectively in Q1 2024, indicating strong market demand for their products. (finance.yahoo.com)
The company raised its full-year 2024 net sales guidance to between $790 million and $795 million, reflecting anticipated growth of 6% to 7% year-over-year, suggesting confidence in sustained revenue expansion. (finance.yahoo.com)
Orthofix's investments in enabling technologies and innovative products, such as the 7D FLASH system, are set to enhance market penetration and competitive advantage, potentially driving future revenue growth. (simplywall.st)
Orthofix Medical reported a net loss of $36 million in Q1 2024, significantly higher than the estimated net loss of $9.73 million, raising concerns about the company's profitability. (finance.yahoo.com)
The company's stock price has declined by 19.33% over the past year, indicating potential investor concerns about its financial performance and future prospects. (simplywall.st)
Orthofix Medical's earnings per share (EPS) for Q4 2023 were reported at -$0.59, missing analyst estimates of -$0.08, which may reflect operational challenges. (investorplace.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

Orthofix Medical Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Orthofix Medical Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OFIX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs